Literature DB >> 31187869

Nivolumab-induced autoimmune encephalitis in an anti-neuronal autoantibody-positive patient.

Ryota Shibaki1, Shuji Murakami1, Koichi Oki2, Yuichiro Ohe1.   

Abstract

Entities:  

Keywords:  anti-Ma2-antibody; encephalitis; immune checkpoint inhibitor; malignant pleural mesothelioma; nivolumab

Year:  2019        PMID： 31187869     DOI： 10.1093/jjco/hyz087

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN： 0368-2811            Impact factor:   3.019


× No keyword cloud information.
  8 in total

1.  How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update.

Authors:  Alberto Vogrig; Sergio Muñiz-Castrillo; Antonio Farina; Jérôme Honnorat; Bastien Joubert
Journal:  J Neurol       Date:  2021-10-27       Impact factor: 4.849

2.  Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature.

Authors:  Yining Gao; Jie Pan; Dingding Shen; Lisheng Peng; Zhifeng Mao; Chunxia Wang; Huanyu Meng; Qinming Zhou; Sheng Chen
Journal:  Brain Sci       Date:  2022-06-13

Review 3.  Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice.

Authors:  M Villagrán-García; R Velasco
Journal:  Neurol Sci       Date:  2022-02-17       Impact factor: 3.830

Review 4.  Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New.

Authors:  Diego Franciotta; Lorenzo Lorusso; Matteo Gastaldi; Silvia Scaranzin; Businaro Pietro; Anastasia Lechiara; Giampaola Pesce
Journal:  Curr Oncol Rep       Date:  2022-04-27       Impact factor: 5.945

5.  Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review.

Authors:  Laure Thouvenin; Timothée Olivier; Giuseppe Banna; Alfredo Addeo; Alex Friedlaender
Journal:  Ther Adv Drug Saf       Date:  2021-03-29

6.  Anti-GAD65 Antibody-Associated Autoimmune Encephalitis With Predominant Cerebellar Involvement Following Toripalimab Treatment: A Case Report of a Novel irAE of Toripalimab.

Authors:  Huanyu Zhou; Xiaoxi Xie; Tianyu Zhang; Menghan Yang; Dong Zhou; Tianhua Yang
Journal:  Front Immunol       Date:  2022-03-25       Impact factor: 7.561

7.  Anti-Ma2-Associated Limbic Encephalitis after Termination of Immune Checkpoint Inhibitor Therapy for Malignant Pleural Mesothelioma.

Authors:  Rei Hashimoto; Etsuko Tanabe; Yoshihisa Otsuka; Yukihiro Yoneda; Yasufumi Kageyama
Journal:  Case Rep Neurol       Date:  2021-11-08

Review 8.  Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis.

Authors:  John E Greenlee; Noel G Carlson; Justin R Abbatemarco; Ida Herdlevær; Stacey L Clardy; Christian A Vedeler
Journal:  Front Neurol       Date:  2022-01-17       Impact factor: 4.003
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.